Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ralf Rastert is active.

Publication


Featured researches published by Ralf Rastert.


Magnetic Resonance Imaging | 1999

Quantitative MR temperature monitoring of high-intensity focused ultrasound therapy.

Christian Bohris; Wolfgang Schreiber; J̈urgen Jenne; I. Simiantonakis; Ralf Rastert; Hans Joachim Zabel; Peter E. Huber; Reiner Bader; Gunnar Brix

A new quantitative method has been developed for real-time mapping of temperature changes induced by high intensity focused ultrasound (HIFU). It is based on the temperature dependence of the T1 relaxation time and the equilibrium magnetization. To calibrate the temperature measurement, the functional relationship between T1 and temperature was examined in different samples of porcine muscle and fatty tissue. The method was validated by a comparison of calculated temperature maps with fiber-optic measurements in heated muscle tissue. The experiment showed that the accuracy of the MR method for temperature measurements is better than 1 degree C. Since the acquisition time of the employed MR sequence takes only 3 s per slice and the calculation of the temperature map can be performed within seconds, the imaging technique works nearly in real-time. The temperature measurement could be realized during HIFU showing no disturbances by ultrasound sonication. In comparison to other MR approaches, the advantages of the introduced method lie in a sufficient accuracy and time resolution combined with a reasonable robustness against motion as well as the feasibility for temperature monitoring in fatty tissues.


Physics in Medicine and Biology | 1999

Control of cavitation activity by different shockwave pulsing regimes.

Peter E. Huber; Jürgen Debus; K. Jöchle; I. Simiantonakis; Jürgen W. Jenne; Ralf Rastert; J. Spoo; Walter J. Lorenz; Michael Wannenmacher

The aim of the study was to control the number of inertial cavitation bubbles in the focal area of an electromagnetic lithotripter in water independently of peak intensity, averaged intensity or pressure waveform. To achieve this, the shockwave pulses were applied in double pulse sequences, which were administered at a fixed pulse repetition frequency (PRF) of 0.33 Hz. The two pulses of a double pulse were separated by a variable short pulse separation time (PST) ranging from 200 micros to 1500 ms. The number and size of the cavitation bubbles were monitored by scattered laser light and stroboscopic photographs. We found that the number of inertial cavitation bubbles as a measure of cavitation dose was substantially influenced by variation of the PST, while the pressure pulse waveform, averaged acoustic intensity and bubble size were kept constant. The second pulse of each double pulse generated more cavitation bubbles than the first. At 14 kV capacitor voltage, the total number of cavitation bubbles generated by the double pulses increased with shorter PST down to approximately 400 micros, the cavitation lifespan. The results can be explained by cavitation nuclei generated by the violently imploding inertial cavitation bubbles. This method of pulse administration and cavitation monitoring could be useful to establish a cavitation dose-effect relationship independently of other acoustic parameters.


internaltional ultrasonics symposium | 1997

CT on-line monitoring of HIFU therapy

Jürgen W. Jenne; M. Bahner; J. Spoo; Peter E. Huber; Ralf Rastert; I. Simiantonakis; Walter J. Lorenz; Jürgen Debus

It was the aim of this study to evaluate the feasibility of a clinical CT scanner for temperature mapping in high intensity focused ultrasound tumor therapy. The authors used a 1.2 MHz ultrasound transducer for HIFU on fresh pig muscle. Image acquisition was performed with a clinical CT Scanner before, during and after HIFU. They were able to determine the spatial and temporal temperature development during HIFU application as hypodense zones in the performed images. Thermal necroses were shown as hyperdense areas in the CT images. Moreover, the authors were able to detect bubble formation due to vaporization during US application. Calibration showed a CT thermosensitivity of -0.43 HU//spl deg/C in pig muscle tissue.


Magnetic Resonance Imaging | 2001

MR monitoring of focused ultrasound surgery in a breast tissue model in vivo

Christian Bohris; Jürgen W. Jenne; Ralf Rastert; I. Simiantonakis; Gunnar Brix; J. Spoo; Michal Hlavac; Robert Nemeth; Peter E. Huber; Jürgen Debus

The objective of this study was to investigate MRI methods for monitoring focused ultrasound surgery (FUS) of breast tumors. To this end, the mammary glands of sheep were used as tissue model. The tissue was treated in vivo with numerous single sonications which covered extended target volumes by employing a scanning technique. The ultrasound focus position was controlled by online temperature mapping based on the temperature dependence of the relaxation time T(1). This approach proved to be reliable and offers thus an alternative to proton resonance frequency methods, whose application is hampered in fatty tissues. FUS-induced tissue changes were visible on T(2)- as well as on pre- and post-contrast T(1)-weighted images. According to our initial experience, noninvasive MRI-guided FUS of breast tumors is feasible.


Radiologe | 2001

Kernspingesteuerte Therapie mit fokussiertem Ultraschall: Nichtinvasive Chirurgie des Mammakarzinoms?

Peter E. Huber; Ralf Rastert; I. Simiantonakis; D. Röder; M. Hlavac; M. Wannenmacher; Jürgen Debus; Jürgen W. Jenne

ZusammenfassungDie magnetresonanzgesteuerte fokussierte Ultraschallchirurgie (MRgFUS: Magnet Resonance guided Focused Ultrasound Surgery) hat das Potenzial, eine relevante Therapiemodalität in der adjuvanten, neoadjuvanten oder auch palliativen onkologischen Situation zu werden. Mögliche klinische Ziele sind ultraschallzugängliche Weichteiltumoren. Wegen ihrer exponierten und wenig atemverschieblichen Lage zählen hierzu insbesondere Tumoren der Mamma.Fokussierter Ultraschall ist physikalisch gesehen das einzige Verfahren, mit dem echte nichtinvasive Chirurgie unter gleichzeitigem kernspintomographischen Temperaturmonitoring realisiert werden kann. Nach einer Einstrahlzeit von wenigen Sekunden entsteht im Schallfokus lokal eine so hohe Temperatur (60–85°C), dass das Tumorgewebe umgehend nekrotisiert werden kann.In der vorliegenden Arbeit stellen wir die in Heidelberg erfolgte Entwicklung und den Aufbau einer klinisch an einem 1,5-T-Ganzkörper-MR-Tomographen einsetzbare Ultraschalltherapieeinheit sowie deren Transfer vom physikalischen Experiment bis zum klinischen Einsatz dar. Wir zeigen damit durchgeführte Experimente an verschieden Phantomen und Ex-vivo-Geweben und demonstrieren In-vivo-Experimente an der Mamma von Schafen als Modell für die menschliche Mamma. Ausgehend von den erfolgreichen Tierstudien berichten wir über die Therapie an der humanen Mamma bis hin zum ersten erfolgreichen Einsatz der MRgFUS beim Mammakarzinom am Menschen in Heidelberg. Über die klinische Rolle dieses neuen, nichtinvasiven, interventionellen radiologischen Therapieverfahrens müssen nun klinische Studien entscheiden.AbstractMagnetic resonance guided focused ultrasound surgery (MRgFUS) has the potential to become an important therapy modality in the adjuvant, neoadjuvant or palliative cancer treatment. All ultrasound accessible regions are possible target areas, especially breast tumors.Ultrasound propagation is well predictable. The ultrasound energy can be focused to a defined spot through the intact skin, and temperatures of 60°C to 85°C can be induced locally for a few seconds that instantaneously necrose biological tissues, while sparing surrounding healthy tissue. In addition, MRI is sensitive to temperature allowing for online monitoring of the temperature focus.In this work we demonstrate our Heidelberg experiments from basic research and animal studies towards the clinical realization of MRgFUS in breast cancer patients. The most important of these experiments involved sheep as an appropriate model for the human breast. A new therapy setup is designated to treat human breast patients in a clinical 1.5 T MRI scanner. While the therapies have been successful so far without any side effects, the future clinical role of noninvasive MRgFUS has to be defined by clinical studies.


internaltional ultrasonics symposium | 2000

Treatment acceleration by modification of sound fields and sonication modalities

Ralf Rastert; I. Simiantonakis; M. Moosmann; Peter E. Huber; Jürgen Debus; Jürgen W. Jenne

High intensity focused ultrasound can produce a small tissue necrosis deeply inside the body. By setting several of these lesions next to each other a larger volume, e.g. a tumor, can be coagulated non-invasively. Normally the tumor which has to be treated has a volume of several cm/sup 3/, whereas a single ultrasound lesion typically has only a volume of a few mm/sup 3/. Therefore, a lot of single ultrasound shots are needed to treat the whole tumor, resulting in a long treatment time. In this study several approaches were investigated to reduce the time. Therefore we have investigated several methods: lenses, a different sonication order and ultrasound exposure during transducer movement. We achieved results comparable to the normal treatment, while the treatment time was reduced by a factor of more than eight.


Zeitschrift Fur Medizinische Physik | 2003

Vergleich nichtinvasiver MRT-Verfahren zur Temperaturmessung für den Einsatz bei medizinischen Thermotherapien

Guido Rademaker; Jürgen W. Jenne; Ralf Rastert; Daniel Röder; Lothar-R. Schad

Novel methods for hyperthermia tumor therapy, such as high-intensity focused ultrasound (HIFU) or laser-induced thermotherapy (LITT), require accurate non-invasive temperature monitoring. Non-invasive temperature measurement using magnetic resonance imaging (MRI) is based on the analysis of changes in longitudinal relaxation time (T1), diffusion coefficient (D), or water proton resonance frequency (PRF). The purpose of this study was the development and comparative analysis of the three different approaches of MRI temperature monitoring (T1, D, and PRF). Measurements in phantoms (e.g., ultrasound gel) resulted in the following percent changes: T1-relaxation time: 1.98%/degree C; diffusion coefficient: 2.22%/degree C; and PRF: -0.0101 ppm/degree C. All measurements were in good agreement with the literature. Temperature resolutions could also be measured from the inverse correlation of the data over the whole calibration range: T1: 2.1 +/- 0.6 degrees C; D: 0.93 +/- 0.2 degree C; and PRF: 1.4 +/- 0.3 degrees C. The diffusion and PRF methods were not applicable in fatty tissue. The use of the diffusion method was restricted due to prolonged echo time and anisotropic diffusion in tissue. Initial tests with rabbit muscle tissue in vivo indicated that MR thermometry via T1 and PRF procedures is feasible to monitor the local heating process induced by HIFU. The ultrasound applicators in the MR scanner did not substantially interfere with image quality.


internaltional ultrasonics symposium | 2001

MRI guided focused ultrasound surgery for the treatment of breast cancer

Jürgen W. Jenne; Ralf Rastert; I. Simiantonakis; Jürgen Debus; Peter E. Huber

HIFU is an effective tool to generate precise localized tissue heating and subsequent tissue necroses deep in the body. Especially in combination with MRI target definition, detection of the heated area and the detection of morphological tissue changes are possible. After previous animal trials we show in the present study the transfer of this method to the clinical application. We have treated human breast cancer with HIFU under MRI guidance. For this purpose, a clinical treatment unit was developed and built up. A prospective clinical phase I study was started involving patients with biopsy proven invasive breast cancer. MRI-guided focused ultrasound therapy was applied before conventional breast surgery. On MR-images breast tumor delineation, tumor segmentation and HIFU treatment planning was possible. During ultrasound therapy, detection of the thermal focus and comparison with the planned focus position allowed a quasi on-line therapy control. Immediately after ultrasound therapy affected areas could be distinguished after intravenous application of MRI contrast agent as non-perfused area. Thus we could demonstrate that breast cancer in a human patient can be treated non-invasively in a single therapy session with HIFU under MRI guidance.


Zeitschrift Fur Medizinische Physik | 2003

MRT-überwachte Chirurgie mit hochenergetischem fokussiertem Ultraschall

Jürgen W. Jenne; Ralf Rastert; Guido Rademaker; Gabriela Wilzbach Divkovic; Jürgen Debus; Peter E. Huber

High-intensity focused ultrasound allows high-precision, non-invasive thermocoagulation of tissues within seconds, with sparing of surrounding areas. The resulting tissue necrosis is so sharply demarcated that the technique is also defined focused ultrasound surgery (FUS). The combination with magnetic resonance imaging (MRI) allows an exact definition of the target volume and a safe guidance of FUS. The present paper describes the physical equipment necessary to perform MRI-guided FUS, and reports an example of application of this technique for the therapy of breast cancer. Finally, the paper outlines further examples of FUS application and future perspectives.


internaltional ultrasonics symposium | 2002

Enhanced temperature detection for MRI guided focused ultrasound surgery

Ralf Rastert; G. Rademaker; G. Divkovic; Peter E. Huber; Jürgen Debus; Jürgen W. Jenne

Noninvasive treatment of solid tumors with MR guided focused ultrasound surgery (MRgFUS) requires a fast and reliable technique for temperature measurement. The goal of the work described in this paper was to investigate a post-processing method to enhance MRI temperature measurements. Data sets similar to MRI measurements were artificially created and afterward enhanced. As a result a much better temperature prediction was achieved and a higher spatial resolution was obtained.

Collaboration


Dive into the Ralf Rastert's collaboration.

Top Co-Authors

Avatar

Jürgen W. Jenne

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Peter E. Huber

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Jürgen Debus

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar

I. Simiantonakis

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Klaus Braun

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juergen Debus

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar

Juergen Jenne

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Stefan Heckl

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

J. Spoo

German Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge